{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T13:14:27Z","timestamp":1783516467407,"version":"3.55.0"},"posted":{"date-parts":[[2026,7,8]]},"group-title":"In Review","reference-count":78,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:00:00Z","timestamp":1783468800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2026,6,26]]},"abstract":"<title>Abstract<\/title>\n                <p>\n                  New antitubercular agents acting through previously unexploited mechanisms are urgently needed. Using a drug-repurposing platform, we identified TI-374, a hydroxamic acid containing compound that inhibits\n                  <italic>Mycobacterium tuberculosis<\/italic>\n                  (\n                  <italic>Mtb<\/italic>\n                  ) with sub-micromolar potency. Systems analysis, resistance mapping, supplementation assays, and biochemical studies established that TI-374 inhibits two PLP-dependent aminotransferases, AlaA and HisC1, and that its antitubercular activity is driven primarily by irreversible inhibition of AlaA, whereas HisC1 inhibition is only partially reversible. Optimization yielded TI-801, a low-nanomolar AlaA inhibitor. Both compounds remained active against intracellular\n                  <italic>Mtb<\/italic>\n                  in a macrophage infection model, where alanine supplementation did not rescue growth, indicating that host-derived alanine is unlikely to bypass AlaA inhibition. Genetic deletion of\n                  <italic>alaA<\/italic>\n                  attenuated\n                  <italic>Mtb<\/italic>\n                  survival in a murine infection model. Together, these findings support AlaA as a host-relevant metabolic vulnerability in\n                  <italic>Mtb<\/italic>\n                  and TI-801 as a mechanistic chemical probe for its validation as an antitubercular target.\n                <\/p>","DOI":"10.21203\/rs.3.rs-10167651\/v1","type":"posted-content","created":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T12:21:33Z","timestamp":1783513293000},"source":"Crossref","is-referenced-by-count":0,"title":["Induced alanine auxotrophy as a therapeutic strategy against Mycobacterium tuberculosis"],"prefix":"10.21203","author":[{"given":"Menna-Allah W.","family":"Shalaby","sequence":"first","affiliation":[{"name":"Purdue University West Lafayette"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nagabhushana C.","family":"Beeralingappa","sequence":"additional","affiliation":[{"name":"Purdue University West Lafayette"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annadka","family":"Shrinidhi","sequence":"additional","affiliation":[{"name":"Purdue University West Lafayette"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaelle G.","family":"Makafe","sequence":"additional","affiliation":[{"name":"Trudeau Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evan","family":"Nece","sequence":"additional","affiliation":[{"name":"Trudeau Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aditya","family":"Patwardhan","sequence":"additional","affiliation":[{"name":"Trudeau Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Low-Beer","sequence":"additional","affiliation":[{"name":"Trudeau Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsuo","family":"Kuki","sequence":"additional","affiliation":[{"name":"Trudeau Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Sheinerman","sequence":"additional","affiliation":[{"name":"Trudeau Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Weinrick","sequence":"additional","affiliation":[{"name":"Trudeau Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel P.","family":"Flaherty","sequence":"additional","affiliation":[{"name":"Purdue University West Lafayette"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michaelle","family":"Chojnacki","sequence":"additional","affiliation":[{"name":"Trudeau Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"World Health Organization. Global Tuberculosis Report 2025. (Geneva, 2025). doi:978 92 4 156450 2."},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2023.1234785","article-title":"The impact of the COVID-19 pandemic on the global tuberculosis epidemic","volume":"14","author":"Falzon D","year":"2023","unstructured":"Falzon, D., Zignol, M., Bastard, M., Floyd, K. & Kasaeva, T. The impact of the COVID-19 pandemic on the global tuberculosis epidemic. Front. Immunol. 14, 1\u20135 (2023).","journal-title":"Front. Immunol."},{"key":"ref3","article-title":"Antibacterial Agents in Clinical and Preclinical Development: an Overview and analysis","volume":"2021","author":"World Health Organization","year":"2022","unstructured":"World Health Organization. Antibacterial Agents in Clinical and Preclinical Development: an Overview and analysis. World Health Organization 2021 (2022).","journal-title":"World Health Organization"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1093\/cid\/cix992","article-title":"Bedaquiline Resistance: Its Emergence, Mechanism, and Prevention","volume":"66","author":"Nguyen TVA","year":"2018","unstructured":"Nguyen, T. V. A., Anthony, R. M., Ba\u00f1uls, A. L., Vu, D. H. & Alffenaar, J. W. C. Bedaquiline Resistance: Its Emergence, Mechanism, and Prevention. Clinical Infectious Diseases 66, 1625\u20131630 (2018).","journal-title":"Clinical Infectious Diseases"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"3252","DOI":"10.1093\/cid\/ciaa755","article-title":"Delamanid Resistance: Update and Clinical Management","volume":"71","author":"Nguyen TVA","year":"2020","unstructured":"Nguyen, T. V. A. et al. Delamanid Resistance: Update and Clinical Management. Clinical Infectious Diseases 71, 3252\u20133259 (2020).","journal-title":"Clinical Infectious Diseases"},{"key":"ref6","article-title":"Bedaquiline resistance in drug-resistant tuberculosis HIV co-infected patients","author":"Nimmo C","year":"2020","unstructured":"Nimmo, C. et al. Bedaquiline resistance in drug-resistant tuberculosis HIV co-infected patients. European Respiratory Journal (2020).","journal-title":"European Respiratory Journal"},{"key":"ref7","author":"Dartois V","year":"2025","unstructured":"Dartois, V. et al. Next-generation rifamycins for the treatment of mycobacterial infections. Proc. Natl. Acad. Sci. U. S. A. 122, e2423842122 (2025)."},{"key":"ref8","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/s41573-024-00897-5","article-title":"Therapeutic developments for tuberculosis and nontuberculous mycobacterial lung disease","volume":"23","author":"Dartois V","year":"2024","unstructured":"Dartois, V. & Dick, T. Therapeutic developments for tuberculosis and nontuberculous mycobacterial lung disease. Nat. Rev. Drug Discov. 23, 381\u2013403 (2024).","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref9","doi-asserted-by":"crossref","first-page":"7489","DOI":"10.1021\/acs.jmedchem.2c00227","article-title":"Dos Santos, J. L. Tuberculosis Drug Discovery: Challenges and New Horizons","volume":"65","author":"Fernandes GFS","year":"2022","unstructured":"Fernandes, G. F. S., Thompson, A. M., Castagnolo, D., Denny, W. A. & Dos Santos, J. L. Tuberculosis Drug Discovery: Challenges and New Horizons. J. Med. Chem. 65, 7489\u20137531 (2022).","journal-title":"J. Med. Chem."},{"key":"ref10","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1021\/acsinfecdis.7b00255","article-title":"The Expanding Diversity of Mycobacterium tuberculosis Drug Targets","volume":"4","author":"Wellington S","year":"2018","unstructured":"Wellington, S. & Hung, D. T. The Expanding Diversity of Mycobacterium tuberculosis Drug Targets. ACS Infect. Dis. 4, 696\u2013714 (2018).","journal-title":"ACS Infect. Dis."},{"key":"ref11","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1038\/nchembio.2420","article-title":"A small-molecule allosteric inhibitor of Mycobacterium tuberculosis tryptophan synthase","volume":"13","author":"Wellington S","year":"2017","unstructured":"Wellington, S. et al. A small-molecule allosteric inhibitor of Mycobacterium tuberculosis tryptophan synthase. Nat. Chem. Biol. 13, 943\u2013950 (2017).","journal-title":"Nat. Chem. Biol."},{"key":"ref12","author":"Tiwari S","year":"2018","unstructured":"Tiwari, S. et al. Arginine-deprivation-induced oxidative damage sterilizes Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. U. S. A. 115, 9779\u20139784 (2018)."},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1021\/acsinfecdis.5c00393","article-title":"Disruption of De Novo Histidine Biosynthesis of Mycobacterium tuberculosis Affects the Depletion of the Pathogen","author":"Tiwari S","year":"2025","unstructured":"Tiwari, S. et al. Disruption of De Novo Histidine Biosynthesis of Mycobacterium tuberculosis Affects the Depletion of the Pathogen. ACS Infect. Dis. https:\/\/doi.org\/10.1021\/acsinfecdis.5c00393 (2025) doi:10.1021\/acsinfecdis.5c00393.","journal-title":"ACS Infect. Dis."},{"key":"ref14","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1002\/iub.2455","article-title":"Targeting amino acid metabolism of Mycobacterium tuberculosis for developing inhibitors to curtail its survival","volume":"73","author":"Yelamanchi SD","year":"2021","unstructured":"Yelamanchi, S. D. & Surolia, A. Targeting amino acid metabolism of Mycobacterium tuberculosis for developing inhibitors to curtail its survival. IUBMB Life 73, 643\u2013658 (2021).","journal-title":"IUBMB Life"},{"key":"ref15","author":"Berney M","year":"2015","unstructured":"Berney, M. et al. Essential roles of methionine and S-adenosylmethionine in the autarkic lifestyle of Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. U. S. A. 112, 10008\u201310013 (2015)."},{"key":"ref16","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-12224-3","article-title":"Derailing the aspartate pathway of Mycobacterium tuberculosis to eradicate persistent infection","volume":"10","author":"Hasenoehrl EJ","year":"2019","unstructured":"Hasenoehrl, E. J. et al. Derailing the aspartate pathway of Mycobacterium tuberculosis to eradicate persistent infection. Nat. Commun. 10, (2019).","journal-title":"Nat. Commun."},{"key":"ref17","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.1128\/IAI.68.5.2888-2898.2000","article-title":"Attenuation of and protection induced by a leucine auxotroph of Mycobacterium tuberculosis","volume":"68","author":"Hondalus MK","year":"2000","unstructured":"Hondalus, M. K. et al. Attenuation of and protection induced by a leucine auxotroph of Mycobacterium tuberculosis. Infect. Immun. 68, 2888\u20132898 (2000).","journal-title":"Infect. Immun."},{"key":"ref18","first-page":"2978","article-title":"Inactivation of the ilvB1 gene in mycobacterium tuberculosis leads to branched-chain amino acid auxotrophy and attenuation of virulence in mice","volume":"155","author":"Awasthy D","year":"2009","unstructured":"Awasthy, D. et al. Inactivation of the ilvB1 gene in mycobacterium tuberculosis leads to branched-chain amino acid auxotrophy and attenuation of virulence in mice. Microbiology (N. Y). 155, 2978\u20132987 (2009).","journal-title":"Microbiology (N. Y)."},{"key":"ref19","doi-asserted-by":"crossref","first-page":"3927","DOI":"10.1128\/IAI.71.7.3927-3936.2003","article-title":"Glutamine synthetase GlnA1 is essential for growth of Mycobacterium tuberculosis in human THP-1 macrophages and guinea pigs","volume":"71","author":"Tullius MV","year":"2003","unstructured":"Tullius, M. V., Harth, G. & Horwitz, M. A. Glutamine synthetase GlnA1 is essential for growth of Mycobacterium tuberculosis in human THP-1 macrophages and guinea pigs. Infect. Immun. 71, 3927\u20133936 (2003).","journal-title":"Infect. Immun."},{"key":"ref20","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/nrmicro3349","article-title":"Nitrogen metabolism in Mycobacterium tuberculosis physiology and virulence","volume":"12","author":"Gouzy A","year":"2014","unstructured":"Gouzy, A., Poquet, Y. & Neyrolles, O. Nitrogen metabolism in Mycobacterium tuberculosis physiology and virulence. Nat. Rev. Microbiol. 12, 729\u2013737 (2014).","journal-title":"Nat. Rev. Microbiol."},{"key":"ref21","author":"Guida M","year":"2024","unstructured":"Guida, M. et al. Amino Acid Biosynthesis Inhibitors in Tuberculosis Drug Discovery. Pharmaceutics 16, (2024)."},{"key":"ref22","doi-asserted-by":"crossref","DOI":"10.1038\/s42003-021-01926-4","article-title":"De novo histidine biosynthesis protects Mycobacterium tuberculosis from host IFN-\u03b3 mediated histidine starvation","volume":"4","author":"Dwivedy A","year":"2021","unstructured":"Dwivedy, A. et al. De novo histidine biosynthesis protects Mycobacterium tuberculosis from host IFN-\u03b3 mediated histidine starvation. Commun. Biol. 4, (2021).","journal-title":"Commun. Biol."},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.chembiol.2013.06.012","article-title":"13C-flux spectral analysis of host-pathogen metabolism reveals a mixed diet for intracellular mycobacterium tuberculosis","volume":"20","author":"Beste DJV","year":"2013","unstructured":"Beste, D. J. V. et al. 13C-flux spectral analysis of host-pathogen metabolism reveals a mixed diet for intracellular mycobacterium tuberculosis. Chem. Biol. 20, 1012\u20131021 (2013).","journal-title":"Chem. Biol."},{"key":"ref24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003928","article-title":"Mycobacterium tuberculosis Exploits Asparagine to Assimilate Nitrogen and Resist Acid Stress during Infection","volume":"10","author":"Gouzy A","year":"2014","unstructured":"Gouzy, A. et al. Mycobacterium tuberculosis Exploits Asparagine to Assimilate Nitrogen and Resist Acid Stress during Infection. PLoS Pathog. 10, (2014).","journal-title":"PLoS Pathog."},{"key":"ref25","doi-asserted-by":"crossref","first-page":"112537","DOI":"10.1016\/j.isci.2025.112537","article-title":"Early preclinical development of Mycobacterium tuberculosis amino acid biosynthesis pathway inhibitor DRILS-1398 as a potential anti-TB drug","volume":"28","author":"Biswas D","year":"2025","unstructured":"Biswas, D. et al. Early preclinical development of Mycobacterium tuberculosis amino acid biosynthesis pathway inhibitor DRILS-1398 as a potential anti-TB drug. iScience 28, 112537 (2025).","journal-title":"iScience"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.2174\/15680266113136660203","article-title":"Targeting the histidine pathway in Mycobacterium tuberculosis","volume":"13","author":"Lunardi J","year":"2013","unstructured":"Lunardi, J. et al. Targeting the histidine pathway in Mycobacterium tuberculosis. Curr. Top. Med. Chem. 13, 2866\u20132884 (2013).","journal-title":"Curr. Top. Med. Chem."},{"key":"ref27","doi-asserted-by":"crossref","first-page":"7132","DOI":"10.1021\/jacs.7b00962","article-title":"Rational Optimization of Mechanism-Based Inhibitors through Determination of the Microscopic Rate Constants of Inactivation","volume":"139","author":"Eiden CG","year":"2017","unstructured":"Eiden, C. G., Maize, K. M., Finzel, B. C., Lipscomb, J. D. & Aldrich, C. C. Rational Optimization of Mechanism-Based Inhibitors through Determination of the Microscopic Rate Constants of Inactivation. J. Am. Chem. Soc. 139, 7132\u20137135 (2017).","journal-title":"J. Am. Chem. Soc."},{"key":"ref28","doi-asserted-by":"crossref","first-page":"18194","DOI":"10.1021\/ja204036t","article-title":"Mechanism-based inactivation by aromatization of the transaminase BioA involved in biotin biosynthesis in mycobaterium tuberculosis","volume":"133","author":"Shi C","year":"2011","unstructured":"Shi, C. et al. Mechanism-based inactivation by aromatization of the transaminase BioA involved in biotin biosynthesis in mycobaterium tuberculosis. J. Am. Chem. Soc. 133, 18194\u201318201 (2011).","journal-title":"J. Am. Chem. Soc."},{"key":"ref29","doi-asserted-by":"crossref","first-page":"10315","DOI":"10.1021\/acs.jmedchem.5c03325","article-title":"Design, Synthesis and Biological Evaluation of Potent Piperazine-Based BioA Inhibitors Targeting Biotin Biosynthesis in Mycobacterium tuberculosis","volume":"69","author":"Liu Q","year":"2026","unstructured":"Liu, Q. et al. Design, Synthesis and Biological Evaluation of Potent Piperazine-Based BioA Inhibitors Targeting Biotin Biosynthesis in Mycobacterium tuberculosis. J. Med. Chem. 69, 10315\u201310337 (2026).","journal-title":"J. Med. Chem."},{"key":"ref30","doi-asserted-by":"crossref","DOI":"10.1038\/s41564-022-01307-5","article-title":"Biotin-dependent cell envelope remodelling is required for Mycobacterium abscessus survival in lung infection","volume":"8","author":"Sullivan MR","year":"2023","unstructured":"Sullivan, M. R. et al. Biotin-dependent cell envelope remodelling is required for Mycobacterium abscessus survival in lung infection. Nat. Microbiol. 8, (2023).","journal-title":"Nat. Microbiol."},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/j.tube.2023.102317","article-title":"A Novel Chemogenomic Discovery Platform Identifies Bioactive Hits with Rapid Bactericidal Activity Against Mycobacteroides Abscessus","volume":"100322","author":"Guiewa G","year":"2023","unstructured":"Guiewa, G. et al. A Novel Chemogenomic Discovery Platform Identifies Bioactive Hits with Rapid Bactericidal Activity Against Mycobacteroides Abscessus. Tuberculosis 100322 (2023) doi:10.1016\/j.tube.2023.102317.","journal-title":"Tuberculosis"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-020-15876-8","article-title":"Aspartate aminotransferase Rv3722c governs aspartate-dependent nitrogen metabolism in Mycobacterium tuberculosis","volume":"11","author":"Jansen RS","year":"2020","unstructured":"Jansen, R. S. et al. Aspartate aminotransferase Rv3722c governs aspartate-dependent nitrogen metabolism in Mycobacterium tuberculosis. Nat. Commun. 11, 1\u201313 (2020).","journal-title":"Nat. Commun."},{"key":"ref33","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02133-16","article-title":"Comprehensive essentiality analysis of the Mycobacterium tuberculosis genome via saturating transposon mutagenesis","volume":"8","author":"Dejesus MA","year":"2017","unstructured":"Dejesus, M. A. et al. Comprehensive essentiality analysis of the Mycobacterium tuberculosis genome via saturating transposon mutagenesis. mBio 8, (2017).","journal-title":"mBio"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"e0061026","DOI":"10.1128\/mbio.00610-26","article-title":"Utilization of a CRISPRi-based ex vivo challenge model to reveal temporally dependent gene essentiality in intracellular Mycobacterium tuberculosis","volume":"17","author":"Theriault ME","year":"2026","unstructured":"Theriault, M. E. et al. Utilization of a CRISPRi-based ex vivo challenge model to reveal temporally dependent gene essentiality in intracellular Mycobacterium tuberculosis. mBio 17, e0061026 (2026).","journal-title":"mBio"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1086\/652497","article-title":"Genetic requirements for the survival of tubercle bacilli in primates","volume":"201","author":"Dutta NK","year":"2010","unstructured":"Dutta, N. K. et al. Genetic requirements for the survival of tubercle bacilli in primates. Journal of Infectious Diseases 201, 1743\u20131752 (2010).","journal-title":"Journal of Infectious Diseases"},{"key":"ref36","author":"Sassetti CM","year":"2003","unstructured":"Sassetti, C. M. & Rubin, E. J. Genetic requirements for mycobacterial survival during infection. Proc. Natl. Acad. Sci. U. S. A. 100, 12989\u201312994 (2003)."},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1101\/2025.10.27.684782","article-title":"Exploiting Vitamin B6 Dependency: BVL3572S Inhibits HisC and AlaA to Kill Mycobacterium tuberculosis","author":"Edoo Z","year":"2025","unstructured":"Edoo, Z. et al. Exploiting Vitamin B6 Dependency: BVL3572S Inhibits HisC and AlaA to Kill Mycobacterium tuberculosis. Preprint at https:\/\/doi.org\/10.1101\/2025.10.27.684782 (2025)."},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1016\/j.bmcl.2013.02.039","article-title":"PF-04859989 as a template for structure-based drug design: Identification of new pyrazole series of irreversible KAT II inhibitors with improved lipophilic efficiency","volume":"23","author":"Dounay AB","year":"2013","unstructured":"Dounay, A. B. et al. PF-04859989 as a template for structure-based drug design: Identification of new pyrazole series of irreversible KAT II inhibitors with improved lipophilic efficiency. Bioorg. Med. Chem. Lett. 23, 1961\u20131966 (2013).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref39","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1039\/C2MD20166F","article-title":"Discovery of hydroxamate bioisosteres as KAT II inhibitors with improved oral bioavailability and pharmacokinetics","volume":"4","author":"Henderson JL","year":"2013","unstructured":"Henderson, J. L. et al. Discovery of hydroxamate bioisosteres as KAT II inhibitors with improved oral bioavailability and pharmacokinetics. Medchemcomm 4, 125\u2013129 (2013).","journal-title":"Medchemcomm"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1021\/ml200204m","article-title":"Discovery of brain-penetrant, irreversible kynurenine aminotransferase ii inhibitors for schizophrenia","volume":"3","author":"Dounay AB","year":"2012","unstructured":"Dounay, A. B. et al. Discovery of brain-penetrant, irreversible kynurenine aminotransferase ii inhibitors for schizophrenia. ACS Med. Chem. Lett. 3, 187\u2013192 (2012).","journal-title":"ACS Med. Chem. Lett."},{"key":"ref41","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/s41564-019-0357-1","article-title":"D. Drug repurposing for antimicrobial discovery","volume":"4","author":"Farha MA","year":"2019","unstructured":"Farha, M. A. & Brown, E. D. Drug repurposing for antimicrobial discovery. Nat. Microbiol. 4, 565\u2013577 (2019).","journal-title":"Nat. Microbiol."},{"key":"ref42","article-title":"Mycobacterium tuberculosis complex lineage 5 exhibits high levels of within-lineage genomic diversity and differing gene content compared to the type strain h37rv","volume":"7","author":"N\u2019dira Sanoussi C","year":"2021","unstructured":"N\u2019dira Sanoussi, C. et al. Mycobacterium tuberculosis complex lineage 5 exhibits high levels of within-lineage genomic diversity and differing gene content compared to the type strain h37rv. Microb. Genom. 7, (2021).","journal-title":"Microb. Genom."},{"key":"ref43","doi-asserted-by":"crossref","first-page":"3185","DOI":"10.1128\/JCM.43.7.3185-3191.2005","article-title":"Genomic deletions classify the Beijing\/W strains as a distinct genetic lineage of Mycobacterium tuberculosis","volume":"43","author":"Tsolaki AG","year":"2005","unstructured":"Tsolaki, A. G. et al. Genomic deletions classify the Beijing\/W strains as a distinct genetic lineage of Mycobacterium tuberculosis. J. Clin. Microbiol. 43, 3185\u20133191 (2005).","journal-title":"J. Clin. Microbiol."},{"key":"ref44","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.tube.2007.05.017","article-title":"Genome analysis shows a common evolutionary origin for the dominant strains of Mycobacterium tuberculosis in a UK South Asian community","volume":"87","author":"Men\u00e9ndez MC","year":"2007","unstructured":"Men\u00e9ndez, M. C. et al. Genome analysis shows a common evolutionary origin for the dominant strains of Mycobacterium tuberculosis in a UK South Asian community. Tuberculosis 87, 426\u2013436 (2007).","journal-title":"Tuberculosis"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1089\/jir.2005.25.694","article-title":"Hypervirulent M. tuberculosis W\/Beijing strains upregulate Type I IFNs and increase expression of negative regulators of the jak-stat pathway","volume":"25","author":"Manca C","year":"2005","unstructured":"Manca, C. et al. Hypervirulent M. tuberculosis W\/Beijing strains upregulate Type I IFNs and increase expression of negative regulators of the jak-stat pathway. Journal of Interferon and Cytokine Research 25, 694\u2013701 (2005).","journal-title":"Journal of Interferon and Cytokine Research"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1006\/jmbi.2001.5080","article-title":"Assignment of homology to genome sequences using a library of hidden Markov models that represent all proteins of known structure","volume":"313","author":"Gough J","year":"2001","unstructured":"Gough, J., Karplus, K., Hughey, R. & Chothia, C. Assignment of homology to genome sequences using a library of hidden Markov models that represent all proteins of known structure. J. Mol. Biol. 313, 903\u2013919 (2001).","journal-title":"J. Mol. Biol."},{"key":"ref47","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1046\/j.1365-2958.2002.02779.x","article-title":"Evaluation of a nutrient starvation model of Mycobacterium tuberculosis persistence by gene and protein expression profiling","volume":"43","author":"Betts JC","year":"2002","unstructured":"Betts, J. C., Lukey, P. T., Robb, L. C., McAdam, R. A. & Duncan, K. Evaluation of a nutrient starvation model of Mycobacterium tuberculosis persistence by gene and protein expression profiling. Mol. Microbiol. 43, 717\u2013731 (2002).","journal-title":"Mol. Microbiol."},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1016\/j.chembiol.2023.12.020","article-title":"Beyond antibiotic resistance: The whiB7 transcription factor coordinates an adaptive response to alanine starvation in mycobacteria","author":"Poulton NC","year":"2024","unstructured":"Poulton, N. C. et al. Beyond antibiotic resistance: The whiB7 transcription factor coordinates an adaptive response to alanine starvation in mycobacteria. Cell Chem. Biol. 2023.06.02.543512 (2024) doi:10.1016\/j.chembiol.2023.12.020.","journal-title":"Cell Chem. Biol."},{"key":"ref49","doi-asserted-by":"crossref","first-page":"W398","DOI":"10.1093\/nar\/gkae253","article-title":"MetaboAnalyst 6.0: towards a unified platform for metabolomics data processing, analysis and interpretation","volume":"52","author":"Pang Z","year":"2024","unstructured":"Pang, Z. et al. MetaboAnalyst 6.0: towards a unified platform for metabolomics data processing, analysis and interpretation. Nucleic Acids Res. 52, W398\u2013W406 (2024).","journal-title":"Nucleic Acids Res."},{"key":"ref50","author":"Choi J","year":"2022","unstructured":"Choi, J., Neupane, T., Baral, R. & Jee, J. G. Hydroxamic Acid as a Potent Metal-Binding Group for Inhibiting Tyrosinase. Antioxidants 11, (2022)."},{"key":"ref51","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1021\/cc030039a","article-title":"Hydroxamate-based iron chelators: Combinatorial syntheses of desferrioxamine B analogues and evaluation of binding affinities","volume":"6","author":"Poreddy AR","year":"2004","unstructured":"Poreddy, A. R. et al. Hydroxamate-based iron chelators: Combinatorial syntheses of desferrioxamine B analogues and evaluation of binding affinities. J. Comb. Chem. 6, 239\u2013254 (2004).","journal-title":"J. Comb. Chem."},{"key":"ref52","first-page":"1","article-title":"Antimicrobial activity and resistance: Influencing factors","volume":"8","author":"Li J","year":"2017","unstructured":"Li, J. et al. Antimicrobial activity and resistance: Influencing factors. Front. Pharmacol. 8, 1\u201311 (2017).","journal-title":"Front. Pharmacol."},{"key":"ref53","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1128\/am.20.5.810-814.1970","article-title":"Probability Distribution of Drug-Resistant Mutants in Unselected Populations of Mycobacterium tuberculosis","volume":"20","author":"David HL","year":"1970","unstructured":"David, H. L. Probability Distribution of Drug-Resistant Mutants in Unselected Populations of Mycobacterium tuberculosis. Appl. Microbiol. 20, 810\u2013814 (1970).","journal-title":"Appl. Microbiol."},{"key":"ref54","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1128\/AAC.46.2.267-274.2002","article-title":"Evolution of Drug Resistance in Mycobacterium tuberculosis: Clinical and Molecular Perspective","volume":"46","author":"Gillespie SH","year":"2002","unstructured":"Gillespie, S. H. Evolution of Drug Resistance in Mycobacterium tuberculosis: Clinical and Molecular Perspective. Antimicrob. Agents Chemother. 46, 267\u2013274 (2002).","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref55","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ab.2011.05.029","article-title":"Impact of enzyme concentration and residence time on apparent activity recovery in jump dilution analysis","volume":"416","author":"Copeland RA","year":"2011","unstructured":"Copeland, R. A., Basavapathruni, A., Moyer, M. & Scott, M. P. Impact of enzyme concentration and residence time on apparent activity recovery in jump dilution analysis. Anal. Biochem. 416, 206\u2013210 (2011).","journal-title":"Anal. Biochem."},{"key":"ref56","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ab.2016.02.003","article-title":"Development of a RapidFire mass spectrometry assay and a fluorescence assay for the discovery of kynurenine aminotransferase II inhibitors to treat central nervous system disorders","volume":"501","author":"Lu H","year":"2016","unstructured":"Lu, H. et al. Development of a RapidFire mass spectrometry assay and a fluorescence assay for the discovery of kynurenine aminotransferase II inhibitors to treat central nervous system disorders. Anal. Biochem. 501, 56\u201365 (2016).","journal-title":"Anal. Biochem."},{"key":"ref57","author":"Mileni M","year":"2008","unstructured":"Mileni, M. et al. Structure-guided inhibitor design for human FAAH by interspecies active site conversion. Proc. Natl. Acad. Sci. U. S. A. 105, 12820\u201312824 (2008)."},{"key":"ref58","doi-asserted-by":"crossref","first-page":"e102139","DOI":"10.1371\/journal.pone.0102139","article-title":"Structural Analysis and Mutant Growth Properties Reveal Distinctive Enzymatic and Cellular Roles for the Three Major L-Alanine Transaminases of Escherichia coli","volume":"9","author":"Pe\u00f1a-Soler E","year":"2014","unstructured":"Pe\u00f1a-Soler, E. et al. Structural Analysis and Mutant Growth Properties Reveal Distinctive Enzymatic and Cellular Roles for the Three Major L-Alanine Transaminases of Escherichia coli. PLoS One 9, e102139 (2014).","journal-title":"PLoS One"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0102139","article-title":"Structural analysis and mutant growth properties reveal distinctive enzymatic and cellular roles for the three major L-alanine transaminases of Escherichia coli","volume":"9","author":"Pe\u00f1a-Soler E","year":"2014","unstructured":"Pe\u00f1a-Soler, E. et al. Structural analysis and mutant growth properties reveal distinctive enzymatic and cellular roles for the three major L-alanine transaminases of Escherichia coli. PLoS One 9, 1\u201315 (2014).","journal-title":"PLoS One"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1021\/ml200204m","article-title":"Discovery of brain-penetrant, irreversible kynurenine aminotransferase ii inhibitors for schizophrenia","volume":"3","author":"Dounay AB","year":"2012","unstructured":"Dounay, A. B. et al. Discovery of brain-penetrant, irreversible kynurenine aminotransferase ii inhibitors for schizophrenia. ACS Med. Chem. Lett. 3, 187\u2013192 (2012).","journal-title":"ACS Med. Chem. Lett."},{"key":"ref61","doi-asserted-by":"crossref","first-page":"4579","DOI":"10.1016\/j.cell.2021.06.033","article-title":"Genome-wide gene expression tuning reveals diverse vulnerabilities of M. tuberculosis","volume":"184","author":"Bosch B","year":"2021","unstructured":"Bosch, B. et al. Genome-wide gene expression tuning reveals diverse vulnerabilities of M. tuberculosis. Cell 184, 4579\u20134592.e24 (2021).","journal-title":"Cell"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"6702","DOI":"10.1128\/JB.185.22.6702-6706.2003","article-title":"Starvation Survival Response of Mycobacterium tuberculosis","volume":"185","author":"Parish T","year":"2003","unstructured":"Parish, T. Starvation Survival Response of Mycobacterium tuberculosis. J. Bacteriol. 185, 6702\u20136706 (2003).","journal-title":"J. Bacteriol."},{"key":"ref63","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1021\/ml300237v","article-title":"Structure-based design of irreversible human KAT II inhibitors: Discovery of new potency-enhancing interactions","volume":"4","author":"Tuttle JB","year":"2013","unstructured":"Tuttle, J. B. et al. Structure-based design of irreversible human KAT II inhibitors: Discovery of new potency-enhancing interactions. ACS Med. Chem. Lett. 4, 37\u201340 (2013).","journal-title":"ACS Med. Chem. Lett."},{"key":"ref64","first-page":"329","volume-title":"Macrophage Infection Models for Mycobacterium tuberculosis BT - Mycobacteria Protocols","author":"Johnson BK","year":"2015","unstructured":"Johnson, B. K. & Abramovitch, R. B. Macrophage Infection Models for Mycobacterium tuberculosis BT - Mycobacteria Protocols. in (eds. Parish, T. & Roberts, D. M.) 329\u2013341 (Springer New York, New York, NY, 2015). doi:10.1007\/978-1-4939-2450-9_20."},{"key":"ref65","author":"Ann L","year":"2024","unstructured":"Ann, L. et al. The Galaxy platform for accessible, reproducible, and collaborative data analyses: 2024 update The Galaxy platform for accessible, reproducible, and collabor ativ e data analyses: 2024 update The Galaxy Community *. Nucleic Acids Res. 2024, 83\u201394 (2024)."},{"key":"ref66","doi-asserted-by":"crossref","first-page":"i884","DOI":"10.1093\/bioinformatics\/bty560","article-title":"An ultra-fast all-in-one FASTQ preprocessor","volume":"34","author":"Chen S","year":"2018","unstructured":"Chen, S., Zhou, Y., Chen, Y. & Gu, J. Fastp: An ultra-fast all-in-one FASTQ preprocessor. Bioinformatics 34, i884\u2013i890 (2018).","journal-title":"Bioinformatics"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/nmeth.1923","article-title":"Fast gapped-read alignment with Bowtie 2","volume":"9","author":"Langmead B","year":"2012","unstructured":"Langmead, B. & Salzberg, S. L. Fast gapped-read alignment with Bowtie 2. Nat. Methods 9, 357\u2013359 (2012).","journal-title":"Nat. Methods"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","article-title":"An efficient general purpose program for assigning sequence reads to genomic features","volume":"30","author":"Liao Y","year":"2014","unstructured":"Liao, Y., Smyth, G. K. & Shi, W. FeatureCounts: An efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics 30, 923\u2013930 (2014).","journal-title":"Bioinformatics"},{"key":"ref69","first-page":"1","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love MI","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 1\u201321 (2014).","journal-title":"Genome Biol."},{"key":"ref70","doi-asserted-by":"crossref","first-page":"D506","DOI":"10.1093\/nar\/gky1049","article-title":"a worldwide hub of protein knowledge","volume":"47","author":"UniProt","year":"2019","unstructured":"UniProt: a worldwide hub of protein knowledge. Nucleic Acids Res. 47, D506\u2013D515 (2019).","journal-title":"Nucleic Acids Res."},{"key":"ref71","author":"Gouet P","year":"1999","unstructured":"Gouet, P., Courcelle, E., Stuart, D. I. & M\u00e9toz, F. ESPript: Analysis of multiple sequence alignments in PostScript. Bioinformatics 15, 305\u2013308 (1999)."},{"key":"ref72","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S1046-5928(02)00024-4","article-title":"Removal of DnaK contamination during fusion protein purifications","volume":"25","author":"Rial DV","year":"2002","unstructured":"Rial, D. V. & Ceccarelli, E. A. Removal of DnaK contamination during fusion protein purifications. Protein Expr. Purif. 25, 503\u2013507 (2002).","journal-title":"Protein Expr. Purif."},{"key":"ref73","author":"Martin RG","unstructured":"Martin, R. G. et al. Enzymes and intermediates of histidine biosynthesis in Salmonella typhimurium. in Methods in enzymology vol. 17 3\u201344 (Elsevier, 1971)."},{"key":"ref74","doi-asserted-by":"crossref","first-page":"7877","DOI":"10.1016\/j.tet.2004.06.115","article-title":"S)-CH3NCH (CH2Ph) CH2] 3N: a new C3-symmetric enantiomerically pure proazaphosphatrane","volume":"60","author":"You J","year":"2004","unstructured":"You, J., Wroblewski, A. E. & Verkade, J. G. P [(S, S, S)-CH3NCH (CH2Ph) CH2] 3N: a new C3-symmetric enantiomerically pure proazaphosphatrane. Tetrahedron 60, 7877\u20137883 (2004).","journal-title":"Tetrahedron"},{"key":"ref75","doi-asserted-by":"crossref","first-page":"3484","DOI":"10.1021\/jo200530j","article-title":"A General Strategy for the Synthesis of Cyclic N-Aryl Hydroxamic Acids via Partial Nitro Group Reduction","volume":"76","author":"McAllister LA","year":"2011","unstructured":"McAllister, L. A. et al. A General Strategy for the Synthesis of Cyclic N-Aryl Hydroxamic Acids via Partial Nitro Group Reduction. J. Org. Chem. 76, 3484\u20133497 (2011).","journal-title":"J. Org. Chem."},{"key":"ref76","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1021\/ol400490s","article-title":"Total Synthesis of Pyoverdin D","volume":"15","author":"Mashiach R","year":"2013","unstructured":"Mashiach, R. & Meijler, M. M. Total Synthesis of Pyoverdin D. Org. Lett. 15, 1702\u20131705 (2013).","journal-title":"Org. Lett."},{"key":"ref77","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1016\/j.tetasy.2004.05.013","article-title":"A practical synthesis of (R)- and (S)-3-amino-3,4-dihydro-1H-quinolin-2-one","volume":"15","author":"Hulin B","year":"2004","unstructured":"Hulin, B. & Lopaze, M. G. A practical synthesis of (R)- and (S)-3-amino-3,4-dihydro-1H-quinolin-2-one. Tetrahedron Asymmetry 15, 1957\u20131958 (2004).","journal-title":"Tetrahedron Asymmetry"},{"key":"ref78","doi-asserted-by":"crossref","first-page":"5211","DOI":"10.1016\/j.tetlet.2011.07.083","article-title":"Synthesis of ortho-substituted nitroaromatics via improved Negishi coupling conditions","volume":"52","author":"Tuttle JB","year":"2011","unstructured":"Tuttle, J. B. et al. Synthesis of ortho-substituted nitroaromatics via improved Negishi coupling conditions. Tetrahedron Lett. 52, 5211\u20135213 (2011).","journal-title":"Tetrahedron Lett."}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-10167651\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-10167651\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T12:21:45Z","timestamp":1783513305000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-10167651\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,8]]},"references-count":78,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-10167651\/v1","relation":{},"subject":[],"published":{"date-parts":[[2026,7,8]]},"subtype":"preprint"}}